Experienced Product Manager, Proteomics

NanoString Technologies
Job Location
Seattle, WA 98109
Competitive Comp Package

Stock Options, ESPP, Matching 401K, Salary DOE, Bonus, and more

Relocation assistance available

Job Description


Nanostring is seeking an innovative Product Manager with experience in commercializing protein immunoassay technologies. Nanostring has a strong culture around developing and launching exciting products to measure DNA and RNA in precious clinical samples. Today, the capability extends beyond nucleic acids to include proteins. Nanostring is looking to build a similar culture of excellence for the development of protein and RNA:Protein products. The right individual will be self-motivated, energetic and excited about developing novel products and creating new markets. The ideal candidate will have technical and marketing experience related to protein technologies. The candidate will demonstrate a thorough understanding of current market needs for protein analysis and emerging protein technologies.

Job Description:

Product Manager will be responsible for commercializing Nanostring's next generation RNA:Protein products. The product manager will lead the effort to define, design and commercialize RNA:Protein. Develop product profiles, competitive analysis, presentations, demos, white papers, and product updates for organizational marketing materials. Identify customer needs and market trends and recommend pricing strategies. Research competitor products and maintain competitive comparisons and evaluations.

Key Responsibilities:

  • Market Research: Perform quality and quantitative market research to understand customer segment, customer need, and competitive landscape 
  • Product development: Ability to define product concept, create product positioning and value propositions, write product requirements, propose pricing strategies, and generate financial models.
  • Go to Market Strategy: Plan key programs and/or events related to product promotion, trade shows, user group events, and other customer-focused events related to the RNA:Protein products.
  • Commercial support: Train field team on specific product details, support customer inquiries, and engage early access customers.
  • Minimum degree in Life Sciences (BSc)
  • Preferred advanced degree in Life Science or Business (MSc, PhD, or MBA)
  • >5 years experience in technical or commercial role related to protein products
  • Experience in managing immunoassay products for applications like IHC, flow, westerns, ELISAs
  • Experience in managing clinical immunoassay products
  • Self-motivated, highly organized, and meticulous in details
  • Must be able to work independently, manage multiple projects, communicate proactively, and prioritize daily tasks
  • Ability to travel >30%
About Our Organization

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer.

Organizations performing cancer research, biomarker validation and screening, and next-generation sequencing validation are rapidly adopting the nCounter® Analysis System. By providing simple, multiplexed digital profiling of single molecules, the NanoString platform represents a natural, digital downstream companion to next-generation sequencing and enables researchers to embark on studies that were previously inconceivable.

Leading researchers and institutions are finding that NanoString's nCounter system provides the ideal platform on which to validate their discoveries and translate them into clinically useful diagnostic assays. The nCounter system is uniquely positioned to support translational research because it provides more reproducible results than methods requiring amplification, and generates high-quality data from the difficult sample types common in clinical research, including Formalin-Fixed Paraffin-Embedded (FFPE) tissues.

In addition to continuing to extend the applications for the nCounter system in the discovery, target validation and routine testing segments of the genomics research market, the company's goal is to become the platform of choice for diagnostic testing based on multiplexed gene signatures that can be offered in hospitals and pathology laboratories worldwide, following appropriate regulatory approvals. These two synergistic areas of business focus provide researchers with a seamless transition from discovery to diagnostics.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.